SAN FRANCISCO — McKesson on Thursday announced that Brian Tyler has been appointed EVP corporate strategy and business development, effective immediately. Tyler succeeds Marc Owen, who joined McKesson Specialty Health as president earlier this year. Tyler will remain president of McKesson’s U.S. Pharmaceutical business while the company searches for his successor.
